A detailed history of Tokio Marine Asset Management CO LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 21,105 shares of BMRN stock, worth $1.41 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
21,105
Previous 20,932 0.83%
Holding current value
$1.41 Million
Previous $1.72 Million 13.93%
% of portfolio
0.07%
Previous 0.08%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$69.02 - $93.84 $11,940 - $16,234
173 Added 0.83%
21,105 $1.48 Million
Q2 2024

Jul 26, 2024

BUY
$74.43 - $92.22 $32,600 - $40,392
438 Added 2.14%
20,932 $1.72 Million
Q1 2024

May 02, 2024

SELL
$83.81 - $99.0 $57,326 - $67,716
-684 Reduced 3.23%
20,494 $1.79 Million
Q4 2023

Feb 02, 2024

SELL
$76.22 - $98.51 $20,731 - $26,794
-272 Reduced 1.27%
21,178 $2.04 Million
Q3 2023

Nov 02, 2023

SELL
$85.07 - $94.48 $89,153 - $99,015
-1,048 Reduced 4.66%
21,450 $1.9 Million
Q2 2023

Jul 28, 2023

SELL
$86.68 - $100.3 $80,439 - $93,078
-928 Reduced 3.96%
22,498 $1.95 Million
Q1 2023

May 11, 2023

BUY
$87.74 - $117.27 $53,784 - $71,886
613 Added 2.69%
23,426 $2.28 Million
Q4 2022

Jan 26, 2023

SELL
$80.93 - $108.63 $56,893 - $76,366
-703 Reduced 2.99%
22,813 $0
Q3 2022

Nov 10, 2022

BUY
$82.16 - $96.94 $29,413 - $34,704
358 Added 1.55%
23,516 $1.99 Million
Q2 2022

Aug 09, 2022

SELL
$71.48 - $86.85 $361,474 - $439,200
-5,057 Reduced 17.92%
23,158 $1.92 Million
Q1 2022

May 13, 2022

BUY
$74.28 - $92.69 $72,051 - $89,909
970 Added 3.56%
28,215 $2.18 Million
Q4 2021

Jan 26, 2022

BUY
$71.72 - $91.47 $103,348 - $131,808
1,441 Added 5.58%
27,245 $2.41 Million
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $224 - $256
-3 Reduced 0.01%
25,804 $1.99 Million
Q2 2021

Aug 12, 2021

SELL
$75.51 - $84.79 $60,785 - $68,255
-805 Reduced 3.02%
25,807 $2.15 Million
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $20,326 - $24,667
272 Added 1.03%
26,612 $2.01 Million
Q4 2020

Feb 16, 2021

SELL
$72.61 - $90.2 $57,216 - $71,077
-788 Reduced 2.9%
26,340 $2.31 Million
Q3 2020

Nov 09, 2020

SELL
$71.87 - $131.03 $128,503 - $234,281
-1,788 Reduced 6.18%
27,128 $2.06 Million
Q2 2020

Aug 07, 2020

SELL
$79.55 - $124.22 $82,334 - $128,567
-1,035 Reduced 3.46%
28,916 $3.57 Million
Q1 2020

May 12, 2020

BUY
$71.37 - $96.85 $13,917 - $18,885
195 Added 0.66%
29,951 $2.53 Million
Q4 2019

Feb 14, 2020

BUY
$64.27 - $86.37 $5,848 - $7,859
91 Added 0.31%
29,756 $2.52 Million
Q3 2019

Oct 29, 2019

BUY
$67.4 - $85.11 $163,647 - $206,647
2,428 Added 8.91%
29,665 $2 Million
Q2 2019

Jul 25, 2019

BUY
$80.35 - $93.9 $7,633 - $8,920
95 Added 0.35%
27,237 $2.33 Million
Q1 2019

Apr 25, 2019

BUY
$84.2 - $98.62 $12,124 - $14,201
144 Added 0.53%
27,142 $2.41 Million
Q4 2018

Feb 04, 2019

BUY
$80.14 - $106.07 $7,132 - $9,440
89 Added 0.33%
26,998 $2.3 Million
Q3 2018

Oct 23, 2018

SELL
$93.92 - $105.72 $8,922 - $10,043
-95 Reduced 0.35%
26,909 $2.61 Million
Q2 2018

Jul 18, 2018

SELL
$76.01 - $99.03 $31,012 - $40,404
-408 Reduced 1.49%
27,004 $2.54 Million
Q1 2018

May 03, 2018

SELL
$77.67 - $92.63 $34,407 - $41,035
-443 Reduced 1.59%
27,412 $2.22 Million
Q4 2017

Feb 05, 2018

SELL
$80.76 - $95.13 $32,627 - $38,432
-404 Reduced 1.43%
27,855 $2.48 Million
Q3 2017

Oct 30, 2017

SELL
$80.6 - $94.95 $51,503 - $60,673
-639 Reduced 2.21%
28,259 $2.63 Million
Q2 2017

Jan 11, 2018

SELL
N/A
-1,862 Reduced 6.05%
28,898 $2.63 Million
Q1 2017

Jan 11, 2018

SELL
N/A
-7,296 Reduced 19.17%
30,760 $2.7 Million
Q4 2016

Jan 11, 2018

SELL
N/A
-1,062 Reduced 2.71%
38,056 $3.15 Million
Q3 2016

Jan 11, 2018

SELL
N/A
-2,227 Reduced 5.39%
39,118 $3.62 Million
Q2 2016

Jan 11, 2018

SELL
N/A
-143 Reduced 0.34%
41,345 $3.22 Million
Q1 2016

Jan 11, 2018

BUY
N/A
41,488
41,488 $3.42 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Tokio Marine Asset Management CO LTD Portfolio

Follow Tokio Marine Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.